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Abstract
Background: The relationships between the infecting dengue serotype, primary and secondary infection, viremia and
dengue severity remain unclear. This cross-sectional study examined these interactions in adult patients hospitalized with
dengue in Ha Noi.
Methods and Findings: 158 patients were enrolled between September 16 and November 11, 2008. Quantitative RT-PCR,
serology and NS1 detection were used to confirm dengue infection, determine the serotype and plasma viral RNA
concentration, and categorize infections as primary or secondary. 130 (82%) were laboratory confirmed. Serology was
consistent with primary and secondary infection in 34% and 61%, respectively. The infecting serotype was DENV-1 in 42
(32%), DENV-2 in 39 (30%) and unknown in 49 (38%). Secondary infection was more common in DENV-2 infections (79%)
compared to DENV-1 (36%, p,0.001). The proportion that developed dengue haemorrhagic fever (DHF) was 32% for
secondary infection compared to 18% for primary infection (p=0.14), and 26% for DENV-1 compared to 28% for DENV-2.
The time until NS1 and plasma viral RNA were undetectable was shorter for DENV-2 compared to DENV-1 (p#0.001) and
plasma viral RNA concentration on day 5 was higher for DENV-1 (p=0.03). Plasma viral RNA concentration was higher in
secondary infection on day 5 of illness (p=0.046). We didn’t find an association between plasma viral RNA concentration
and clinical severity.
Conclusion: Dengue is emerging as a major public health problem in Ha Noi. DENV-1 and DENV-2 were the prevalent
serotypes with similar numbers and clinical presentation. Secondary infection may be more common amongst DENV-2 than
DENV-1 infections because DENV-2 infections resulted in lower plasma viral RNA concentrations and viral RNA
concentrations were higher in secondary infection. The drivers of dengue emergence in northern Viet Nam need to be
elucidated and public health measures instituted.
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Introduction
Dengue virus (DENV) infections range in severity from
asymptomatic to a syndrome characterized by a haemorrhagic
tendency and vascular permeability [1]. The events that
precipitate endothelial cell dysfunction and vascular leak are
incompletely understood. Numerous studies including several
prospective cohorts [2,3,4] demonstrate that the risk of severe
dengue is higher during a secondary infection with a new serotype
in children [5,6,7]. Severe dengue has also been associated with
high viral loads [8,9,10,11,12], prolonged viremia [13] and high
NS1 antigen levels [12,14]. At sub-neutralizing concentrations,
dengue specific antibodies can enhance dengue virus infection of
mononuclear phagocytes [15]. In addition, antibodies to pre-
membrane protein appear to enhance infection of all serotypes,
even when present at high concentration [16]. It has therefore
been proposed that antibody-dependent enhancement (ADE) of
viremia is a risk factor for severe dengue [1]. However, ADE may
not fully account for severe dengue as several studies have found
no association between severity and secondary infection in adults
[7,17,18,19], or severity and viral load [20,21,22,23]. In one study
dengue virus titers were higher prior to defervescence in patients
with secondary infection [8] but most other studies have found
that titers are either similar or higher in primary infection
[10,17,20,24]. Demonstration of a link between enhancing
antibody levels, viral load and disease severity in humans also
remains elusive.
The emerging picture is that multiple factors including prior
immunity, viral load, age of the patient and infecting serotype and
genotype may contribute to the severity of dengue infection
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Dengue pathogenesis has largely been studied in dengue hyper-
endemic regions where analysis is ‘‘confounded by a multiplicity of
preexisting immunity patterns coupled with co-circulation of
multiple serotypes’’ [3,27]. Studies in low transmission settings,
where few dengue serotypes circulate and primary infection in
adults is common, potentially offer an opportunity to better
identify factors associated with severity across serotype and
immunity groups. We conducted a prospective study in Ha Noi,
Viet Nam, to examine the association between primary and
secondary infections, serotype, plasma viral RNA concentration,
and the development of dengue haemorrhagic fever (DHF) in a
low transmission setting.
Methods
Patient recruitment and clinical investigations
The protocol for this study was approved by the scientific and
ethical committees at the National Hospital of Tropical Diseases
and The Oxford University Tropical Research Ethics Committee
(OXTREC). Patients provided written informed consent to
participate in this study.
Patients were eligible for recruitment if they were admitted to the
National Hospital of Tropical Diseases (NHTD) in Ha Noi, Viet
Nam between September and November 2008 with a clinical
diagnosis of dengue according to the WHO criteria [28]. These
criteria were fever plus two or more of the following: headache;
retro-orbital pain; myalgia/arthralgia; rash; bleeding or leukopenia.
The study protocol included children but the number attending the
National Hospital of Pediatrics (NHP) in Ha Noi during the study
period was too low to warrant investigation. The NHTD is a 160
bed tertiary care center for adult patients with infectious diseases
and also serves as a referral center for dengue in Northern Viet
Nam. The NHP is the coordinating center for pediatric care in the
country, receives patients from all Northern provinces and sees on
average 40,000 in-patients and 350,000 out-patients per year.
Patients were examined daily during hospitalization by a
dedicated team of physicians with experience in dengue diagnosis
and treatment. Signs and symptoms of hemorrhage, capillary
permeability and shock along with other relevant clinical data
were prospectively recorded using standardized case record forms.
Ultrasound of the chest and abdomen was performed at study
enrolment and additionally when clinically indicated. Full blood
counts were performed daily for at least 6 days during admission,
as well as at discharge and approximately 10 days after discharge.
Other investigations and clinical management were at the
discretion of the attending physicians. CRFs and laboratory results
were reviewed to identify patients that fulfilled the WHO criteria
for dengue hemorrhagic fever (DHF), i.e. plasma leakage, plus
thrombocytopenia and hemorrhagic signs [28]. Plasma leakage
was said to be evident if pleural effusion and/or ascites were
detected by ultrasound, or if a haematocrit during admission was
$20% higher than at follow-up. If the patient did not attend
follow-up, the average of follow-up values for males (n=60,
average =44) or females (n=56, average =38) was used. This
compares to a normal haematocrit value of 38% with a range of
35–41% set by the Ministry of Health of Viet Nam. Thrombo-
cytopenia was defined as a platelet count less than 100,000/mm
3.
Dengue Diagnostics
An in-house IgM & IgG capture ELISA using antigens from
DENV 1-4 and monoclonal antibodies provided by Venture
Technologies (Sarawak, Malaysia) was performed as previously
described [29]. A sample was considered IgM or IgG positive if the
units were at least 6 times higher than the negative control sera.
An internally controlled, serotype-specific, real-time reverse-
transcriptase polymerase chain reaction (RT-PCR) assay [30]
was used to identify the infecting serotype and determine viral
RNA concentrations expressed as cDNA equivalents/ml of
plasma. The sequences of the dengue serotype-specific primers
and probes have been published previously [30]. They amplify
and detect parts of the NS5 coding region that were first identified
by Laue et al as being highly conserved within each dengue
serotype [31]. The assay limit of detection was 10 cDNA
equivalents per reaction. Dengue NS1 antigen was detected using
a commercial ELISA (BIO-RAD Platelia
TM Dengue NS1 Ag)
according to the manufacturer’s instructions. A diagnosis of
confirmed dengue was made using a previously described
reference algorithm [32] that has been adapted to include NS1
ELISA and remove the indirect recombinant membrane protein
ELISA, which was not used in this study (Figure S1). Using this
algorithm a patient is considered to have confirmed dengue if
either RT-PCR or NS1 ELISA is positive, if there is an increase in
the level of IgM detected by ELISA or an IgG ELISA conversion
in the presence of a positive IgM ELISA. Serology was considered
to be consistent with primary dengue infection if on or after day 6
of illness IgM levels were at least 1.78 times higher than IgG levels
[33], or with secondary infection if IgM levels were less than 1.2
times higher than IgG levels.
Data analysis
Illness day was calculated from the first date that the patient
recalled having fever, which was assigned as day 1. Proportions
were compared using odds ratios and Chi-Square or Fishers exact
test when any expected cell count was less than 5. Continuous
variables were presented as medians and interquartile ranges
(IQR) and compared using Kruskal-Wallis and Mann Whitney
tests. Data for study patients was compared to records kept by the
Ha Noi Preventive Medicine Center (Ha Noi PMC), which
includes age, gender, province and district of people attending
government health care facilities with a clinical diagnosis of
dengue by month and year.
Author Summary
Dengue is estimated to affect 50 million people each year
and can occur as explosive outbreaks that overwhelm
health systems. Despite significant advances the available
knowledge is not sufficient to predict the outcome of
individual infections or the occurrence of epidemics.
Studies from low dengue transmission settings are lacking
but offer the potential to better understand the contribu-
tion of age, primary versus secondary infection and
serotype because there are likely to be more adult and
primary infection patients and fewer serotypes circulating
compared to high transmission settings. This is the first
reported study of clinical dengue in Ha Noi, the largest
urban area of Northern Viet Nam. Records kept by the
Preventive Medicine Center indicate that ,2500 clinical
dengue cases attended government health care facilities in
Ha Noi each year from 1999 until 2007. Patients in Ha Noi
were older than in high transmission settings, the
contribution of primary infection to overt and severe
illness was greater and associations between serotype,
plasma viral RNA concentration and overt and severe
illness were distinct. The dengue situation in Ha Noi
provides an opportunity to further examine the roles of
serotype and prior immunity in dengue severity and
epidemic emergence.
Virology and Immunology of Dengue in Ha Noi
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definition of prior infection/immunity and infecting serotype (and
a potential interaction) using simple and multiple logistic
regression analyses. The probability of a positive NS1 result and
the log-10 plasma viral RNA measurements on day 5 of illness (i.e.
the median illness day when patients were admitted) were
modelled using logistic and linear regression models, respectively,
depending on serological definition of prior infection, infecting
serotype and dengue severity. In a sensitivity analysis, the model
was additionally adjusted for age and gender. The time from
illness onset to the first undetectable NS1 and viral RNA
measurement, respectively, were modelled using Weibull acceler-
ated failure time regression models for interval censored data, i.e.
patients were treated as reaching undetectable levels in the interval
between their last positive and their first undetectable measure-
ment and patients for whom the first measurement was
undetectable were treated as first reaching undetectable levels
between illness day 1 and the day of this first measurement.
Analyses were performed with the statistical software R version
2.9.1 [34] and SPSS for Windows, Rel. 14.0.0.245, 2005 (SPSS
Inc. Chicago IL.).
Results
Characteristics of patients admitted with confirmed
dengue
158 of 206 eligible patients consented and enrolled in an 8 week
period commencing on September 16 2008. During this time
approximately 1240 clinical dengue cases attended government
health care facilities in Ha Noi out of a total of 2371 for the whole
of 2008 of which 975 (41%) were admitted to NHTD. 139 patients
were from Ha Noi province, 11 were from 4 neighboring
provinces and 6 were from more distant provinces, the farthest
being Nhge An, Son La and Quang Ninh which are more than
100 km from Ha Noi. None of the patients were from provinces
north of Ha Noi. Laboratory diagnosis of dengue was made for
130 patients. A further 18 with probable dengue were not included
in this analysis as these were recruited significantly later in their
illness and 61% had already defervesced. 26% of all enrolled
patients and 23% of those with confirmed dengue had been
transferred from another hospital. The age and gender distribution
of confirmed dengue patients (Table 1) were similar to that for
dengue cases attending any government health care facility in Ha
Noi in 2008 (median age 23 years, IQR 18–31, 52% male). The
geographic distribution was also similar to that for all reported
cases in Ha Noi (data not shown). Amongst confirmed cases
serology was indicative of secondary infection in 61% and of
primary infection in 34% (Table 1). The infecting serotype could
be defined by real-time-RT-PCR for 81 patients of which 52%
had DENV-1 and 48% had DENV-2 (Table 1). Viral RNA could
not be detected by RT-PCR in 49 confirmed dengue patients. The
median admission day for these patients was 1 day later than for
those with virus RNA detectable by RT-PCR (Table 1). The E
genes of 9 DENV-2 (GenBank: GU908512- GU908520) and 20
DENV-1 (GenBank: HQ591537-HQ591556) viruses were se-
quenced and belong phylogenetically to the Asian 1 genotype and
Genotype I, respectively (unpublished findings). Secondary
infection was significantly more common in DENV-2 patients
(79%) compared to DENV-1 patients (36%, p,0.001). Age, sex
and course of illness were similar across serotype and serology
subgroups (Table 1). Most patients (91, 70%) were classified as
dengue fever (DF) and 36 (28%) developed DHF, of which 5 were
classified as grade I, 30 as grade II and 1 as grade III. All patients
were well at discharge except one patient who was transferred to
the surgical hospital.
Characteristics of patients with DHF
In patients with DHF platelet counts fell to their lowest levels
and haematocrits increased by the greatest percentage over
baseline on days 5–7 (Figure 1). DHF rates were similar for
DENV-1 and DENV-2 patients (Table 1). There was a non-
significant trend of higher DHF rates in patients with secondary
compared to primary infection (Odds Ratio 1.96, 95% CI 0.80 –
4.85, p=0.14). Results were consistent when including both
serotype and serological definition of primary versus secondary
infection in a logistic model and after adjusting for age and sex
(data not shown), and there was no evidence of an interaction
between serotype and primary/secondary infection status in the
development of DHF (Likelihood ratio p=0.48).
Table 1. Characteristics of confirmed cases categorized by prior immunity and serotype.
Patient Group n (%) % male age Admission day
Days
febrile
Days in
hospital DHF n (%)
All confirmed dengue 130 53 23.5 (21–31) 5 (4–6) 5 (5–6) 5 (4–6) 36 (28)
Primary serology* 44 (34) 61 23 (21–32) 5 (4–6) 5 (4–6) 5 (4–6) 8 (18)
Secondary serology 79 (61) 48 24 (20–31) 5 (4–6) 5 (5–6) 5 (4–7) 25 (32)
DENV-1 42 (32) 57 24 (21–32) 4 (4–5) 5 (4–6) 6 (5–7) 11 (26)
DENV-2 39 (30) 54 23 (21–40) 4 (4–5) 5 (5–6) 5 (4–7) 11 (28)
Serotype-unknown 49 (38) 49 23 (20–30) 5 (5–6) 6 (5–6) 5 (4–6) 14 (29)
DENV-1 Primary * 24 (18) 62 23.5 (21–32) 4.5 (4–6) 5 (4–6) 6 (4–6) 5 (21)
Secondary 15 (11) 53 24 (22–32) 4 (4–6) 5 (5–6) 6 (5–7) 5 (33)
DENV-2 Primary 8 (6) 62 23 (22–26) 4.5 (4–6) 5 (4–6) 5 (4–6) 2 (25)
Secondary 31 (24) 52 25 (20–42) 4 (4–5) 6 (5–6) 5 (4–7) 9 (29)
Serotype-
unknown
Primary* 12 (9) 58 22.5 (20–33) 5 (4–6) 6 (5–7) 4 (3–5) 1 (8)
Secondary 33 (25) 42 24 (20–28) 4 (4–5) 5 (5–6) 5 (4–6) 11 (33)
*Serology to define prior infection status was indeterminate for 7 patients (5%) including 3 DENV-1 and 4 serotype-unknown patients.
doi:10.1371/journal.pntd.0000967.t001
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The proportion NS1 positive on day 5 of illness was significantly
higher for DENV-1 compared to DENV-2 patients and the time
to undetectable NS1 was shorter for DENV-2 (Table 2, Figure 2).
The proportion NS1 positive on day 5 was similar for patients with
primary and secondary infection but the time to undetectable was
shorter for secondary infection. There was no evidence of an
interaction between serotype and primary/secondary infection
status (Likelihood ratio =0.24) and effects were consistent when
the analysis was additionally adjusted for age and gender. There
was also no evidence of any association between NS1 and DHF
(Table 2).
Association between serotype, serology and plasma viral
RNA concentration
Log10 viral RNA concentration in plasma on day 5 was
estimated to be 0.96 lower for DENV-2 than for DENV-1 patients
and the time taken until viral RNA was undetectable in plasma
was estimated to be 0.89 times shorter for DENV-2 (Table 3,
Figure 3). Plasma viral RNA concentration on day 5 was
significantly higher in patients with secondary infection, but the
time taken until viral RNA was undetectable in plasma was not
significantly different. Results were consistent after adjusting for
age and sex (data not shown) and likelihood ratio tests showed no
evidence of interaction between serotype and primary/secondary
infection status for either viral RNA concentration on day 5
(p=0.96) or time taken until viral RNA was undetectable
(p=0.85). We couldn’t establish a clear association between
DHF and plasma viral RNA concentration on day 5 or time taken
until viral RNA was undetectable in plasma.
Discussion
Hospitalized dengue patients in Ha Noi in 2008 were
predominantly adults with high rates of primary infection
compared to Southern Vietnam [35] and other hyper-endemic
regions [36,37]. DENV-1 and DENV-2 were the only serotypes
identified, consistent with national dengue surveillance data for Ha
Noi (Le Quynh Mai, personal communication), whereas in
Southern Viet Nam all serotypes were detected during clinical
dengue surveillance in 2008 but DENV-1 was predominant [38].
Overall case numbers and clinical presentation were similar for
DENV-1 and DENV-2. However, while primary infection
predominated amongst DENV-1 patients suggesting that a
substantial proportion of adults are dengue naı ¨ve, secondary
infection predominated in DENV-2. This suggests that primary
DENV-2 infections may be less likely to present clinically.
A limitation of this study is that patients were recruited from
only one hospital in Hanoi. However, the patients studied
represented ,12% of dengue cases seeking treatment for dengue
Figure 1. Daily platelet and haematocrit measurements in DF
and DHF patients. The number of DF (94 in total) and DHF patients
(36 in total) assessed each day is shown above or below each box.
Haematocrits were assessed on at least 4 days for 125 of 130 confirmed
dengue patients.
doi:10.1371/journal.pntd.0000967.g001
Table 2. Multiple regression models for prediction of NS1 detection.
Covariate Undetectable NS1 on day 5 Time to undetectable NS1
OR (95%CI) * p-value Effect (95%CI)* p-value
DENV-2 versus DENV-1 13.88 (1.40 to 137.12) 0.02 0.51 (0.41 to 0.63) ,0.001
Unknown versus DENV-1 31.13 (2.54 to 381.97) 0.01 0.61 (0.50 to 0.75) ,0.001
Secondary versus primary 0.74 (0.14 to 3.86) 0.72 0.82 (0.69 to 0.98) 0.03
DHF versus DF 1.57 (0.36 to 6.86) 0.55 0.97 (0.82 to 1.15) 0.74
Logistic regression for modeling the probability of undetectable NS1 on day 5, Weibull regression for time to undetectable NS1. Plasma samples from all (130)
confirmed dengue patients were assessed but only 67 had plasma collected on day 5 of illness including 30 DENV-2, 27 DENV-1 patients and 24 with primary infection
and 40 with secondary infection.
*Multiplicative effect, i.e., the odds for DENV-2 patients to have undetectable NS1 on day 5 is estimated to be by a factor of 13.88 higher than for DENV-1 and the time
to undetectable NS1 for patients with DENV-2 is estimated to be shorter by factor of 0.51.
doi:10.1371/journal.pntd.0000967.t002
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period and had similar epidemiology. We did not include children
as originally intended because only 5 were admitted to the
National Hospital of Pediatrics with clinically suspected dengue
while the study was being conducted. This may be expected if
transmission is low such that secondary infections mainly occur in
adulthood. However it is not clear why children with primary
infection do not present given that 34% of adult patients had
primary infection. Others report that DHF rates during primary
infection are higher for adults and suggest that primary infection is
more severe in adults [39]. Patients that admitted late were not
precluded from this study in order to obtain a comprehensive
description of clinical dengue, however this limited our ability to
detect viral RNA in plasma and determine peak concentrations.
The infecting serotype was unknown for 38% of confirmed dengue
patients most of whom admitted 5 to 6 days after illness onset, and
by day 6 viral RNA could be detected in only 39 of 100 confirmed
patients tested. We suspect that DENV-2 will be the predominant
infecting serotype in this group because viral RNA clearance from
plasma was faster for DENV-2 than for DENV-1 patients in our
study.
Similar to the findings of this study, records kept since 1988
indicate that Dengue case numbers have been low in Ha Noi
and that dengue has predominated in adults (Horby P. et al, in
preparation). This may not reflect transmission because the
proportion of infections that present clinically can be low and
Figure 2. NS1 measurements in DF and DHF patients stratified by serotype and primary versus secondary infection. Plasma samples
collected daily during admission and at follow-up from DF (pink) and DHF (blue) patients were tested by NS1 ELISA and results presented as OD450
sample/OD450 cutoff control.
doi:10.1371/journal.pntd.0000967.g002
Virology and Immunology of Dengue in Ha Noi
www.plosntds.org 5 February 2011 | Volume 5 | Issue 3 | e967the proportion and age-distribution depends on the prevalent
serotypes and the age-associated prevalence of past infection
with each serotype [3,40,41]. However, the age of clinical
dengue cases generally increases with decreasing transmission
intensity [42], and the epidemiology of hospitalized dengue in
this study is similar to that in Singapore where transmission has
decreased due to effective vector control but the age and
proportion of cases with primary dengue has increased,
presumably because adults are more prone to present clinically
upon primary infection [40].
Others have reported that primary DENV-2 infections are
rarely symptomatic [6,36,37,43,44]. The reason for this has not
been established but our data shows that viral RNA concentration
is low and NS1 detection brief in the plasma of DENV-2
compared to DENV-1 patients, factors that could be considered
important in disease pathogenesis leading to severe dengue.
Furthermore, the relatively high prevalence of secondary DENV-2
coincided with higher plasma viral RNA concentrations in
secondary infection. It is important to note that the DENV-2
viruses sequenced in this study belonged to the Asian I genotype,
Figure 3. Viral RNA concentration in DF and DHF patients stratified by serotype and primary versus secondary infection. Plasma
samples collected daily during admission from DF (pink) and DHF (blue) patients were tested by RT-PCR for viral RNA and results expressed as Log10
cDNA equivalents/ml of plasma.
doi:10.1371/journal.pntd.0000967.g003
Table 3. Multiple regression models for prediction of plasma log10 viral RNA concentration and time to undetectable.
Covariate log10-viral RNA concentration on day 5
Time until viral RNA is undetectable in
plasma
Effect (95%CI) * p-value Effect (95%CI)** p-value
DENV-2 versus DENV-1 20.96 (21.78 to 20.13) 0.02 0.89 (0.83 to 0.96) 0.001
Secondary versus primary infection +0.86 (0.01 to 1.71) 0.046 1.06 (0.99 to 1.14) 0.12
DHF versus DF 20.21 (21.03 to 0.61) 0.61 1.03 (0.96 to 1.11) 0.38
Linear regression for modeling the viral RNA concentration in plasma on day 5, Weibull regression for time to undetectable viral RNA. Plasma samples from all (130)
confirmed dengue patients were assessed but only 67 had plasma collected on day 5 of illness as described in Table 2.
*Additive effect.
**Multiplicative effect.
doi:10.1371/journal.pntd.0000967.t003
Virology and Immunology of Dengue in Ha Noi
www.plosntds.org 6 February 2011 | Volume 5 | Issue 3 | e967which has been associated with more severe disease compared to
the American genotype [26] and with higher plasma viral RNA
concentrations compared to Asian/American genotype [38].
While the results suggest that primary infection with DENV-1 is
more likely to lead to clinically overt disease than with DENV-2,
we can not exclude the possibility that secondary infection
contributes to overt DENV-1 or the possibility that DENV-2
infections are more likely to be enhanced than DENV-1 infections.
The latter has been suggested elsewhere [3] and is supported by
several studies showing that in children with secondary infection
DHF is more common for DENV-2 compared to DENV-1 [4,36].
DHF was approximately twice as common in secondary compared
to primary infection in our cohort, but the number of patients with
DHF was small and this did not reach statistical significance or
permit analysis within each serotype. However, in a study of
hospitalized patients in Thailand the association between second-
ary infection and DHF was greater for DENV-2 than DENV-1
because DHF was less common in DENV-2 compared to DENV-
1 during primary infection [34]. As in our study, this suggests that
primary DENV-2 infections may be less virulent than DENV-1.
As discussed above, we suspect that DENV-2 would have been the
predominant infecting serotype amongst confirmed dengue
patients in which the infecting serotype was unknown. NS1
measurements and prior infection status were similar for serotype-
unknown and DENV-2 patients and distinct from DENV-1
patients providing further indication that DENV-1 may be distinct
in terms of virulence during primary infection.
There was a non-significant trend of increased DHF in
secondary infection, but 22% of DHF cases had primary infection.
Thus secondary infection was not essential for DHF in this cohort.
Secondary infection was associated with higher viral RNA
concentration in plasma on day 5 of illness, but we did not find
an association between viral RNA concentration and DHF.
Interpretation of the effect of viral RNA concentration on DHF in
our patients is limited by the relatively low proportion that
developed DHF and perhaps also the high proportion that
presented after day 3 of illness. Several of the studies that find an
association between viremia and DHF recruit children within the
first 3 days of illness and suggest that DHF is positively associated
with peak viremia [8,9,11]. It remains controversial whether virus
clearance times also differ. In one study clearance of infectious
virus determined by mosquito inoculation was faster in children
with DHF compared to DF [8] but studies of adults with DENV-2
or DENV-3 infection [10,13] and children with DENV-2 infection
[24] have found longer times to virus RNA or virus-RNA
containing immune complex clearance amongst those with
DHF[10,13]. It is also possible that we did not detect an
association between DHF and plasma viral RNA concentration
because a relatively high proportion of our patients had primary
DENV-1 and studies where DHF has been associated with viremia
rarely include primary DENV-1 [9,10,11,13,14,24] or reported
that there was no association in patients with primary DENV-1
[8]. The contribution of plasma viral RNA concentration to the
development of DHF may be not be discernable in primary
DENV-1 because plasma viral RNA concentration is generally
high in DENV-1, but this would imply that high viral RNA
concentration alone is not sufficient to cause DHF.
The time until NS1 was undetectable was longer for DENV-1
compared to DENV-2, similar to findings of an earlier study in
Southern Viet Nam [32]. We previously suggested that this
reflected a predominance of primary infection in DENV-1 and
that NS1 clearance is faster in secondary infection due to
sequestration by IgG [32,45]. In the current study there were
sufficient primary cases for a stratified analysis, which demon-
strated that serotype is the main determinant of the sensitivity of
NS1 tests, and this should be considered when interpreting NS1-
based diagnostics.
In conclusion our results indicate an association between
secondary infection and clinically overt DENV-2 infection. Higher
plasma viral RNA concentration in secondary infection may
underlie the association between secondary infection and overt
DENV-2. We could not detect an association between DHF and
secondary infection or plasma viral RNA concentration but this
may be due to the relatively high proportion of patients with
primary DENV-1, a situation that may change if dengue emerges
and the proportion and age of the population that is dengue naı ¨ve
declines.
The number of countries affected by dengue has increased six-
fold in the last 30 years with potential for further spread through
temperate, subtropical and tropical areas [46]. The Ha Noi
Preventive Medicine Centre reported a 7-fold increase in the
number of clinical dengue cases from 2008 to 2009 and this
unforeseen epidemic overwhelmed the health system. A similar
problem is faced in regions where dengue has been endemic for
decades due to large multi-annual peaks in severe disease
incidence [47]. Current understanding of the drivers of dengue
epidemics is inadequate to predict their occurrence and inform
public health prevention and preparedness measures. The dengue
situation in Ha Noi provides an opportunity to further examine
the roles of serotype infection sequence and prior immunity in
dengue severity and emergence.
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